Is MIGS with the Glaukos iStent® safe and effective?

Written by: Mr Sundeep Kheterpal
Published:
Edited by: Top Doctors®

MIGS (minimally invasive glaucoma surgery) using a micro iStent is one of the numerous options available for glaucoma treatment. It’s safe, has a high success rate and has been demonstrated to have long-lasting results.

 

Mr Sundeep Kheterpal has been using the Glaukos iStent® for over six years and has been trained by Glaukos in its implantation procedure. He explains how this tiny device creates such life-changing results for patients and their vision

 

 

What is the Glaukos iStent?

The Glaukos iStent® is one of the new micro-incision implants used to reduce eye pressure in patients with glaucoma. It’s made of titanium and inserted into the front of the eye via a small incision that’s made on the side of the eye. It looks like a plug but it is actually a small tube. At present, I am one of the very few surgeons in the Thames Valley with experience in the procedure and who regularly performs it, having been trained by Glaukos, the company who created it.

 

 

Is there more than one type of micro-incision implant?

Several micro-incision implants are available but some of the earlier ones have been discontinued or have become less popular. The Glaukos iStent, however, has experienced a good track record for several years in terms of safety and efficacy. This is why I continue to use Glaukos iStent when performing minimally invasive glaucoma surgery (MIGS).

 

It has also become very popular in the last couple of years, particularly since the micro-incision glaucoma study (MIGS) in America, in which it had positive outcomes.

 

 

How small is the iStent?

The Glaukos iStent is about 23 millimetres in width and 36 millimetres in length.

 

 

Who can benefit from an iStent?

Micro-incision implants are used particularly in patients with glaucoma who also need cataract surgery and in patients who have already had cataract surgery.

 

We try and avoid it in patients who don’t have a cataract because they have a clear, natural lens and the incision made during MIGS can promote the development of a cataract. Another reason is that as we’re making an incision into the eye, there’s the usual surgical risk of infection, inflammation and bleeding, which we want to try and avoid. However, if we implant the iStent during a cataract procedure, there is very little additional risk.

 

The iStent is used to reduce eye pressure in patients who have glaucoma or high eye pressure. It can also be used in patients with slightly less pressure in the eye that can’t be controlled with drops. To implant the iStent in a patient, the drainage angles of their eye must be open. If drainage is closed, the iStent can’t be used.

 

An iStent generally works very well. It lowers the eye pressure and works as an alternative to glaucoma eye drops and selective laser trabeculoplasty (SLT), which often needs repeated every three to five years. What’s more, an iStent is safer than doing full-thickness surgery i.e. trabeculectomy.

 

 

How is it implanted into the eye?

The iStent is injected into the front of the eye via a small incision on the side of the eye.  When implanted during a cataract procedure, the iStent will be injected at the end of the cataract operation. These days, we usually inject two stents per eye and these are injected into the eye at the same time.

 

You can watch how it’s implanted in a video on the Glaukos website.

 

 

What is the success rate?

The procedure is very successful and eye pressure drops in over 90 per cent of patients.

 

Are there risks?

There is a very small risk of bleeding during the procedure, but this is mild and does not affect the outcome. Occasionally, micro stents can become blocked or fall out but these scenarios don’t cause harm and this is why we now insert two iStents in one injection.

 

 

How long do iStents last?

We don’t know yet as iStents are relatively new. Nevertheless, the results are quite promising. They are made of titanium, so they are very long-lasting and will not disintegrate.

 

 

If iStent isn't an option for glaucoma treatment, what are the alternatives?

If for any reason a patient isn’t eligible for iStent, they may be offered selective laser trabeculoplasty (SLT) or full-thickness glaucoma surgery (trabeculectomy).

 

 

How often should an iStent be checked?

We check the eye regularly after the procedure. The first follow up will take place within the first month after surgery followed by routine glaucoma checks every four to six months.

 

 

Are there typical “dos and don’ts” after MIGS?

The precautions patients need to take after having a micro stent inserted are the same as those advised after cataracts surgery:

  • avoid rubbing your treated eye
  • don’t wear makeup for 10 days
  • don’t go swimming for four weeks

 

 

Can iStents be removed?

There is not usually any need for an iStent to be removed (even if it stops working or becomes dislodged). It’s quite harmless in the eye and doesn’t react to anything within it. They’re safe inside the eye.

 

Take a look at Mr Kheterpal’s profile to learn more about how he can help you care for your eye health.

 

By Mr Sundeep Kheterpal
Ophthalmology

Mr Sundeep Kheterpal is a leading consultant ophthalmologist based in Windsor. He is the director of Windsor Eye Clinic and currently sees his patients at Spire Thames Valley, BMI Princess Margaret Hospital, Bridge Clinic Maidenhead and Nuffield Health Guildford. He has a special interest in refractive surgery (laser vision correction), accommodative and multifocal lens implants, refractive cataract surgery, retina and macula and eyelid plastic surgery as well as all aspects of general ophthalmology.


Having been a consultant at the King Edward VII Hospital Windsor and Royal Berkshire Hospitals NHS Trust for many years, Mr Kheterpal has led the development of many new techniques and services for macular degeneration, diabetic retinopathy, and laser cataract surgery. He was one of the first surgeons in the UK to undertake photodynamic laser and thermal laser for macular degeneration. He was one of the pioneers for the introduction of Lucentis in the Thames Valley.

Mr Sundeep Kheterpal undertook his medical training at Cambridge University and Oxford Clinical School. He trained in ophthalmic surgery at Birmingham and Midland Eye Centre and the world-famous Wills Eye Hospital in Philadelphia. He regularly lectures at local, national and international meetings. He’s a reviewer of both national and international medical journals.

View Profile

Overall assessment of their patients


This website uses its own and third-party cookies to collect information in order to improve our services, to show you advertising related to your preferences, as well as to analyse your browsing habits..